Department of Anaesthesia, University College Hospital, 235 Euston Road, London, NW1 2BU, UK.
Can J Anaesth. 2013 Sep;60(9):840-54. doi: 10.1007/s12630-013-9981-z. Epub 2013 Aug 8.
The influence that different concentrations of labour epidural local anesthetic have on assisted vaginal delivery (AVD) and many obstetric outcomes and side effects is uncertain. The purpose of this meta-analysis was to determine whether local anesthetics utilized at low concentrations (LCs) during labour are associated with a decreased incidence of AVD when compared with high concentrations (HCs).
We searched PubMed, Ovid EMBASE, Ovid MEDLINE, CINAHL, Scopus, clinicaltrials.gov, and Cochrane databases for randomized controlled trials of labouring patients that compared LCs (defined as ≤ 0.1% epidural bupivacaine or ≤ 0.17% ropivacaine) of epidural local anesthetic with HCs for maintenance of analgesia. The primary outcome was AVD and secondary outcomes included Cesarean delivery, duration of labour, analgesia, side effects (nausea and vomiting, motor block, hypotension, pruritus, and urinary retention), and neonatal outcomes. The odds ratios (OR) or weighted mean differences (WMD) and 95% confidence intervals (CI) were calculated using random effects modelling. An OR < 1 or a WMD < 0 favoured LCs.
Eleven studies met our criteria (eight bupivacaine and three ropivacaine studies), providing 1,145 patients in the LCs group and 852 patients in the HCs group for analysis of the primary outcome. Low concentrations were associated with a reduction in the incidence of AVD (OR = 0.70; 95% CI 0.56 to 0.86; P < 0.001). There was no difference in the incidence of Cesarean delivery (OR 1.05; 95% CI 0.82 to 1.33; P = 0.7). The LCs group had less motor block (OR 3.9; 95% CI 1.59 to 9.55; P = 0.003), greater ambulation (OR 2.8; 95% CI 1.1 to 7.14; P = 0.03), less urinary retention (OR 0.42; 95% CI 0.23 to 0.73; P = 0.002), and a shorter second stage of labour (WMD -14.03; 95% CI -27.52 to -0.55; P = 0.04) compared with the HCs group. There were no differences between groups in pain scores, maternal nausea and vomiting, hypotension, fetal heart rate abnormalities, five-minute Apgar scores, and need for neonatal resuscitation. One-minute Apgar scores < 7 favoured the HCs group (OR 1.53; 95% CI 1.07 to 2.21; P = 0.02), and there was more pruritus in the LCs group (OR 3.36; 95% CI 1.00 to 11.31; P = 0.05).
When compared with HCs of local anesthetics, the use of LCs for labour epidural analgesia reduces the incidence of AVD. This may be due to a reduction in the amount of local anesthetic used and the subsequent decrease in motor blockade. We therefore recommend the use of LCs of local anesthetics for epidural analgesia to optimize obstetric outcome.
不同浓度的分娩硬膜外局部麻醉药对辅助阴道分娩(AVD)和许多产科结局及副作用的影响尚不确定。本荟萃分析旨在确定与高浓度(HCs)相比,分娩时使用低浓度(LCs)局部麻醉剂是否与 AVD 的发生率降低相关。
我们检索了 PubMed、Ovid EMBASE、Ovid MEDLINE、CINAHL、Scopus、clinicaltrials.gov 和 Cochrane 数据库,以获取比较硬膜外布比卡因(LCs:定义为≤0.1%或≤0.17%罗哌卡因)与 HCs 维持镇痛的产妇随机对照试验。主要结局为 AVD,次要结局包括剖宫产、产程时间、镇痛、副作用(恶心和呕吐、运动阻滞、低血压、瘙痒和尿潴留)和新生儿结局。使用随机效应模型计算比值比(OR)或加权均数差(WMD)和 95%置信区间(CI)。OR<1 或 WMD<0 有利于 LCs。
11 项研究符合我们的标准(8 项布比卡因和 3 项罗哌卡因研究),LCs 组有 1145 例患者,HCs 组有 852 例患者纳入主要结局分析。LCs 组的 AVD 发生率降低(OR=0.70;95%CI 0.56 至 0.86;P<0.001)。两组剖宫产率无差异(OR=1.05;95%CI 0.82 至 1.33;P=0.7)。LCs 组运动阻滞发生率较低(OR=3.9;95%CI 1.59 至 9.55;P=0.003),活动度更高(OR=2.8;95%CI 1.1 至 7.14;P=0.03),尿潴留发生率较低(OR=0.42;95%CI 0.23 至 0.73;P=0.002),第二产程时间较短(WMD-14.03;95%CI-27.52 至-0.55;P=0.04)。两组疼痛评分、产妇恶心呕吐、低血压、胎儿心率异常、5 分钟 Apgar 评分和新生儿复苏需求无差异。1 分钟 Apgar 评分<7 有利于 HCs 组(OR=1.53;95%CI 1.07 至 2.21;P=0.02),LCs 组瘙痒发生率较高(OR=3.36;95%CI 1.00 至 11.31;P=0.05)。
与 HCs 局部麻醉药相比,LCs 用于分娩硬膜外镇痛可降低 AVD 的发生率。这可能是由于使用的局部麻醉剂减少,随后运动阻滞减少。因此,我们建议使用 LCs 局部麻醉剂进行硬膜外镇痛,以优化产科结局。